Q1 EPS Estimates for agilon health Cut by Leerink Partnrs

agilon health, inc. (NYSE:AGL - Free Report) - Equities researchers at Leerink Partnrs lowered their Q1 2025 earnings estimates for shares of agilon health in a research note issued on Monday, November 11th. Leerink Partnrs analyst W. Mayo now anticipates that the company will earn $0.05 per share for the quarter, down from their prior forecast of $0.08. The consensus estimate for agilon health's current full-year earnings is ($0.35) per share.

AGL has been the topic of a number of other reports. Deutsche Bank Aktiengesellschaft dropped their price objective on shares of agilon health from $5.00 to $4.00 and set a "hold" rating on the stock in a research note on Friday, August 9th. Benchmark reiterated a "buy" rating and issued a $9.00 price target on shares of agilon health in a report on Thursday, August 8th. Citigroup reduced their price target on agilon health from $2.50 to $1.75 and set a "sell" rating for the company in a research report on Wednesday. Barclays dropped their price objective on agilon health from $5.00 to $2.00 and set an "underweight" rating on the stock in a research report on Monday. Finally, Bank of America downgraded shares of agilon health from a "buy" rating to an "underperform" rating and set a $3.00 target price for the company. in a report on Wednesday, October 2nd. Three equities research analysts have rated the stock with a sell rating, fifteen have given a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $6.98.

agilon health Stock Performance

Shares of agilon health stock traded up $0.01 during trading on Wednesday, hitting $1.89. 5,628,709 shares of the stock traded hands, compared to its average volume of 4,975,737. agilon health has a 52-week low of $1.80 and a 52-week high of $13.76. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The stock's fifty day simple moving average is $3.18 and its 200 day simple moving average is $4.93.

agilon health (NYSE:AGL - Get Free Report) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The firm had revenue of $1.45 billion for the quarter, compared to analysts' expectations of $1.47 billion. During the same quarter in the previous year, the business earned ($0.06) earnings per share.

Insider Buying and Selling

In other news, CEO Steven Sell purchased 20,000 shares of the company's stock in a transaction on Thursday, September 12th. The shares were acquired at an average price of $3.36 per share, for a total transaction of $67,200.00. Following the purchase, the chief executive officer now owns 67,590 shares in the company, valued at $227,102.40. This trade represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 3.20% of the stock is currently owned by company insiders.

Institutional Trading of agilon health

Several institutional investors and hedge funds have recently bought and sold shares of AGL. Arizona State Retirement System raised its holdings in shares of agilon health by 2.5% during the second quarter. Arizona State Retirement System now owns 85,989 shares of the company's stock worth $562,000 after purchasing an additional 2,070 shares during the last quarter. Swiss National Bank grew its holdings in agilon health by 0.6% during the first quarter. Swiss National Bank now owns 602,800 shares of the company's stock worth $3,677,000 after acquiring an additional 3,400 shares during the period. J.Safra Asset Management Corp grew its holdings in agilon health by 626.1% during the second quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company's stock worth $27,000 after acquiring an additional 3,625 shares during the period. CWM LLC raised its position in agilon health by 406.5% during the second quarter. CWM LLC now owns 9,081 shares of the company's stock valued at $59,000 after acquiring an additional 7,288 shares in the last quarter. Finally, Signaturefd LLC lifted its holdings in agilon health by 166.2% in the second quarter. Signaturefd LLC now owns 11,848 shares of the company's stock valued at $77,000 after acquiring an additional 7,398 shares during the period.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.